Daiwa Securities Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Daiwa Securities Group’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-40	Closed	-$2K	–	1392
2025 Q4	$2K	Sell	40 -40	-50%	-$1.51K	﹤0.01%	1323
2025 Q3	$2K	Hold	80	–	–	﹤0.01%	1283
2025 Q2	$1K	Hold	80	–	–	﹤0.01%	1281
2025 Q1	$1K	Buy	+80	New	+$1.62K	﹤0.01%	1247
2022 Q4	–	Sell	-37	Closed	–	–	1372
2022 Q3	$0	Hold	37	–	–	﹤0.01%	1384
2022 Q2	$0	Hold	37	–	–	﹤0.01%	1414
2022 Q1	$1K	Hold	37	–	–	﹤0.01%	1334
2021 Q4	$1K	Hold	37	–	–	﹤0.01%	1354
2021 Q3	$1K	Hold	37	–	–	﹤0.01%	1279
2021 Q2	$2K	Hold	37	–	–	﹤0.01%	1152
2021 Q1	$1K	Hold	37	–	–	﹤0.01%	1218
2020 Q4	$1K	Sell	37 -44	-54%	-$1.27K	﹤0.01%	1198
2020 Q3	$2K	Hold	81	–	–	﹤0.01%	1143
2020 Q2	$1K	Hold	81	–	–	﹤0.01%	1193
2020 Q1	$1K	Hold	81	–	–	﹤0.01%	1197
2019 Q4	$2K	Hold	81	–	–	﹤0.01%	1168
2019 Q3	$2K	Hold	81	–	–	﹤0.01%	1135
2019 Q2	$2K	Hold	81	–	–	﹤0.01%	1152
2019 Q1	$2K	Hold	81	–	–	﹤0.01%	1138
2018 Q4	$2K	Hold	81	–	–	﹤0.01%	1110
2018 Q3	$3K	Hold	81	–	–	﹤0.01%	1112
2018 Q2	$2K	Hold	81	–	–	﹤0.01%	1145
2018 Q1	$3K	Buy	+81	New	+$3.24K	﹤0.01%	1106

Other funds holding RIGL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Daiwa Securities Group's RIGL Position: Q1 2026 in Review

Daiwa Securities Group sold out of Rigel Pharmaceuticals (RIGL) in Q1 2026, closing a stake of 40 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in RIGL in Q1 2018 and held it in 23 quarters. The position peaked at $3K in Q3 2018. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

Daiwa Securities Group reported no remaining Rigel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 40 Rigel Pharmaceuticals shares in Q1 2026, an estimated $2K.
Daiwa Securities Group first reported a position in Rigel Pharmaceuticals in Q1 2018 and held it in 23 quarters.
Daiwa Securities Group's Rigel Pharmaceuticals position peaked at $3K in Q3 2018.
159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.